Abstract. To investigate the respective role of triiodothyronine (T3) and thyroxine (T4) 
TSH secretion, we studied the action of sodium ipodate and propylthiouracil (PTU) (Larsen et al. 1979; Kaplan & Utiger 1978; Crantz & Larsen 1980 ). 6-n propylthiouracil (PTU) is also a well known inhibitor of T4 to T3 conversion (Oppenheimer et al. 1972 (Snedecor & Cochran 1967 ).
Results Table 2 shows the sequence of the changes in TSH and iodothyronines and total iodine concentration in ipodate-treated patients.
After ipodate administration, the mean serum T3 concentration significantly decreased from the pre-treatment (day 0) level of 100 ± 3 ng/dl to 36 ± 3 ng/dl by day 4 (P < 0.001). Ten 1) a significant correlation between TSH and T3 in the ipodate (r =-0.30, P<0.01)2 and PTU (r = -0.05, P<0.01)2 groups; 2) no significant difference between slopes but 3) a significant dif¬ ference between intercepts of the two regression lines3 (P < 0.01) (Fig. 1) . In other words, the lower serum T3 levels in ipodate-treated patients did not fully account for their higher serum TSH levels. For the same 3 decrease, a higher ATSH in¬ crease was observed in these patients. (Larsen 1982 and TSH is not well known. However, have shown that, 3 h after iv injec¬ tion of increasing doses of T3 into hypothyroid rats, the plasma T3 concentration correlated with the change in TSH. There was a linear relationship between the nuclear occupancy by T3 and TSH release in rats. Moreover, for a plasma T3 level between 20 and 200 ng/dl, the TSH suppression was linearly related to the increase in plasma T3. Therefore, for both groups in the present study, we assumed a linear relationship between the de¬ crease in serum T3 and the rise in TSH levels. If this assumption is not completely valid, however, analysis of covariance has been shown to be robust with respect to deviation from linearity (Snedecor & Cochran 1967) .
The totality of our data shows that for a similar decrease in serum T3, the rise in serum TSH was higher in the ipodate-treated group than in the PTU-treated patients. The TSH increase and the T3 decrease ratio through day 4 was similar in both groups. However, after day 4, while (Larsen 1982 (Saberi et al. 1975; Geffner et al. 1975 In animals, Silva & Larsen (1977) , Larsen et al. (1979) , Crantz & Larsen (1980) , in the liver and kidney but not in the pituitary . 5'-deiodination of T4 proceeds via a PTU insensitive pathway in the central ner¬ vous system and the pituitary (Larsen 1982) . On the contrary, nearly all the nuclear T3 present in the liver and kidney is derived from plasma T3. Thus, the mixed origin of T3 in the pituitary explains how TSH secretion can be a function of by both plasma T3 and T4 ).
In conclusion, the effects of PTU or ipodate administration on the serum TSH and iodothyronine levels in hypothyroid patients on T4 replace¬ ment therapy were investigated. For 
